Trial Profile
Multi-Centre, Parallel Group, Double-Blind, Placebo Controlled Study of the Efficacy and Tolerability of Tonabersat [Minster Pharmaceuticals] in the Prophylaxis of Migraine Headache
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Jun 2015
Price :
$35
*
At a glance
- Drugs Tonabersat (Primary)
- Indications Migraine
- Focus Adverse reactions; Therapeutic Use
- Sponsors Minster Pharmaceuticals
- 01 Jul 2009 Results were publshed in Cephalalgia.
- 01 Feb 2006 New trial record.